Abbott Joins $575M Whoop Series G at $10.1B Valuation Ahead of IPO
Abbott invested in Whoop’s $575 million Series G round, joining Collaborative Fund and others to support the wearable’s $10.1 billion valuation ahead of an IPO. Participation by Abbott and Mayo Clinic underscores its strategic push into medical-grade preventive health technologies.
1. Abbott's Role in Whoop Funding
Abbott participated in Whoop's $575 million Series G funding round led by Collaborative Fund, at a $10.1 billion valuation, joining investors like Qatar Investment Authority and Mayo Clinic.
2. Whoop's Financial and Operational Performance
Whoop reported 2.5 million members, 103% year-over-year bookings growth, a $1.1 billion bookings run rate and positive operating cash flow in 2025.
3. Implications for Abbott's Preventive Health Strategy
By backing Whoop's medical-grade wearable platform with FDA-cleared ECG and blood pressure monitoring, Abbott strengthens its position in preventive healthcare and digital health analytics ahead of Whoop's planned IPO.